India High Court Suit Seeks Strong Action Against Ranbaxy, Directors
This article was originally published in PharmAsia News
A public-interest lawsuit has been filed with India's Supreme Court seeking closure of two production plants of Ranbaxy Laboratories and prosecution of the firm's former and current directors.
You may also be interested in...
Non-profit approach is reassuring for healthcare payers, but vaccines won’t be ready to stop pandemic at its peak.
Executives On The Move: BMS Taps Barclays Exec For Strategy Spot, Epizyme Selects Science Chief And A Board Election At ADC Therapeutics
Bristol-Myers Squibb taps Barclays chair of global life sciences as it EVP, strategy and business development, and cancer therapeutics firm Epizyme Inc. selects a chief scientific officer. At ADC Therapeutics, an oncology drug development company, a new chairman is elected.